{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T17:44:39Z","timestamp":1788716679968,"version":"build-2803163510"},"reference-count":221,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004846","name":"Beijing University of Chinese Medicine","doi-asserted-by":"publisher","award":["DZMYJS2025010"],"award-info":[{"award-number":["DZMYJS2025010"]}],"id":[{"id":"10.13039\/501100004846","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Aspects of Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.mam.2026.101490","type":"journal-article","created":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:13:04Z","timestamp":1782533584000},"page":"101490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine"],"prefix":"10.1016","volume":"110","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8694-893X","authenticated-orcid":false,"given":"Shihao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan-e","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoke","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobin","family":"Zao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.mam.2026.101490_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.slasd.2023.08.007","article-title":"Key aspects of modern GPCR drug discovery","volume":"29","author":"Addis","year":"2024","journal-title":"SLAS Discovery : Advancing Life Sciences R & D"},{"key":"10.1016\/j.mam.2026.101490_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/nyas.15012","article-title":"Nonalcoholic liver disease: epidemiology, risk factors, natural history, and management strategies","volume":"1526","author":"Agyapong","year":"2023","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib3","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.jhep.2019.10.003","article-title":"The gut-liver axis in liver disease: pathophysiological basis for therapy","volume":"72","author":"Albillos","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/1744666X.2023.2198209","article-title":"The CD8+ T cell exhaustion mechanisms in chronic hepatitis B infection and immunotherapeutic strategies: a systematic review","volume":"19","author":"Allahmoradi","year":"2023","journal-title":"Expert Rev. Clin. Immunol."},{"key":"10.1016\/j.mam.2026.101490_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","article-title":"Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries","volume":"391","author":"Allemani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2026.101490_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.mcpro.2023.100561","article-title":"Multi-omics profiling for health","volume":"22","author":"Babu","year":"2023","journal-title":"Mol. Cell. Proteomics"},{"key":"10.1016\/j.mam.2026.101490_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1111\/liv.13986","article-title":"Potential mechanisms linking gut microbiota and portal hypertension","volume":"39","author":"Baffy","year":"2019","journal-title":"Liver Int."},{"key":"10.1016\/j.mam.2026.101490_bib9","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jhep.2021.12.003","article-title":"Promises of microbiome-based therapies","volume":"76","author":"Bajaj","year":"2022","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib10","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1002\/hep.31537","article-title":"Gallstones, body mass index, C-Reactive protein, and gallbladder cancer: mendelian randomization analysis of Chilean and European genotype data","volume":"73","author":"Barahona Ponce","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2026.101490_bib7","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1126\/science.1104816","article-title":"Host-bacterial mutualism in the human intestine","volume":"307","author":"B\u00e4ckhed","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.mam.2026.101490_bib11","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/s41467-020-20422-7","article-title":"Gut microbiota impact on the peripheral immune response in non-alcoholic fatty liver disease related hepatocellular carcinoma","volume":"12","author":"Behary","year":"2021","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101490_bib12","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1157\/13127094","article-title":"Translocaci\u00f3n de productos de origen bacteriano en la cirrosis [Bacterial translocation in cirrhosis]","volume":"31","author":"Bellot","year":"2008","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib13","doi-asserted-by":"crossref","DOI":"10.1128\/ecosalplus.esp-0001-2018","article-title":"Function and biogenesis of lipopolysaccharides","volume":"8","author":"Bertani","year":"2018","journal-title":"EcoSal Plus"},{"key":"10.1016\/j.mam.2026.101490_bib14","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.clnu.2009.10.002","article-title":"Short chain fatty acids exchange: is the cirrhotic, dysfunctional liver still able to clear them?","volume":"29","author":"Bloemen","year":"2010","journal-title":"Clinical Nutrition (Edinburgh, Scotland)"},{"key":"10.1016\/j.mam.2026.101490_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2021.100333","article-title":"Deep stool microbiome analysis in cirrhosis reveals an association between short-chain fatty acids and hepatic encephalopathy","volume":"25","author":"Bloom","year":"2021","journal-title":"Ann. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib16","first-page":"751","article-title":"Hepatocellular carcinoma: current state of the art in diagnosis and treatment. Best Practice and Research","volume":"28","author":"Bruix","year":"2014","journal-title":"Clinical Gastroenterology"},{"key":"10.1016\/j.mam.2026.101490_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu11051132","article-title":"Transcriptome analysis of dual FXR and GPBAR1 agonism in rodent model of NASH reveals modulation of lipid droplets formation","volume":"11","author":"Carino","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/j.mam.2026.101490_bib18","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2026.101490_bib20","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.21873\/invivo.13308","article-title":"Comparing the influences of metformin and berberine on the intestinal microbiota of rats with nonalcoholic steatohepatitis","volume":"37","author":"Chen","year":"2023","journal-title":"In Vivo (Athens)"},{"key":"10.1016\/j.mam.2026.101490_bib21","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.fsi.2022.06.062","article-title":"Salvia miltiorrhiza polysaccharide activated macrophages and improved the disease resistance of sturgeon against Aeromonas hydrophila","volume":"127","author":"Chen","year":"2022","journal-title":"Fish Shellfish Immunol."},{"key":"10.1016\/j.mam.2026.101490_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.01979-23","article-title":"Ling-Gui-Zhu-Gan decoction ameliorates nonalcoholic fatty liver disease via modulating the gut microbiota","volume":"12","author":"Chen","year":"2024","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.mam.2026.101490_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13020-025-01233-8","article-title":"5,7-dimethoxyflavone inhibits hepatocellular carcinoma progression via increasing intestinal Akkermansia muciniphila and hepatic CD8+ T cell infiltration","volume":"20","author":"Chen","year":"2025","journal-title":"Chin. Med."},{"key":"10.1016\/j.mam.2026.101490_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115825","article-title":"Biejiajian pill inhibits progression of hepatocellular carcinoma by downregulating PDGFR\u03b2 signaling in cancer-associated fibroblasts","volume":"301","author":"Chen","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib25","article-title":"Pharmacological activities of safflower yellow and its clinical applications","volume":"2022","author":"Chen","year":"2022","journal-title":"Evid. Based Complement. Alternat. Med."},{"key":"10.1016\/j.mam.2026.101490_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/s11655-023-3542-2","article-title":"Efficacy of Biejiajian pill on intestinal microbiota in patients with hepatitis B cirrhosis\/liver fibrosis: a randomized double-blind controlled trial","volume":"29","author":"Chi","year":"2023","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.mam.2026.101490_bib19","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1053\/j.gastro.2017.01.055","article-title":"Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia, and nonalcoholic fatty liver disease","volume":"152","author":"Ch\u00e1vez-Talavera","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2026.101490_bib27","doi-asserted-by":"crossref","first-page":"6304","DOI":"10.3748\/wjg.v26.i41.6304","article-title":"Efficacy and safety of anti-hepatic fibrosis drugs","volume":"26","author":"Damiris","year":"2020","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mam.2026.101490_bib28","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1016\/j.ccr.2012.02.007","article-title":"Promotion of hepatocellular carcinoma by the intestinal microbiota and TLR4","volume":"21","author":"Dapito","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.mam.2026.101490_bib29","article-title":"Signalling pathways in hepatocellular carcinoma (HCC) metastasis and invasion: molecular mechanisms and therapeutic implications","volume":"45","author":"Das","year":"2025","journal-title":"Biochem. Biophys. Rep."},{"key":"10.1016\/j.mam.2026.101490_bib30","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00203-020-01931-x","article-title":"Human microbiome: an academic update on human body site specific surveillance and its possible role","volume":"202","author":"Dekaboruah","year":"2020","journal-title":"Arch. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116945","article-title":"Enhancing NKT cell-mediated immunity against hepatocellular carcinoma: role of XYXD in promoting primary bile acid synthesis and improving gut microbiota","volume":"318","author":"Deng","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib32","doi-asserted-by":"crossref","first-page":"13","DOI":"10.2174\/012772574X269376231107095831","article-title":"Therapeutic potential and clinical effectiveness of quercetin: a dietary supplement","volume":"15","author":"Devi","year":"2024","journal-title":"Recent Advances in Food, Nutrition & Agriculture"},{"key":"10.1016\/j.mam.2026.101490_bib33","first-page":"257","article-title":"Lipopolysaccharide structures of Gram-negative populations in the gut microbiota and effects on host interactions","volume":"43","author":"Di Lorenzo","year":"2019","journal-title":"FEMS (Fed. Eur. Microbiol. Soc.) Microbiol. Rev."},{"key":"10.1016\/j.mam.2026.101490_bib34","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","article-title":"A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement","volume":"73","author":"Eslam","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-15430-5","article-title":"The relation between gallstone disease and cardiovascular disease","volume":"7","author":"Fan","year":"2017","journal-title":"Sci. Rep."},{"issue":"Suppl. 4","key":"10.1016\/j.mam.2026.101490_bib35","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/jgh.12244","article-title":"Role of diet and nutritional management in non-alcoholic fatty liver disease","volume":"28","author":"Fan","year":"2013","journal-title":"J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/nu15224829","article-title":"Dietary and nutritional interventions in nonalcoholic fatty liver disease in pediatrics","volume":"15","author":"Far\u00edas","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/j.mam.2026.101490_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2023.108517","article-title":"SCFAs switch stem cell fate through HDAC inhibition to improve barrier integrity in 3D intestinal organoids from patients with obesity","volume":"26","author":"Farhadipour","year":"2023","journal-title":"iScience"},{"key":"10.1016\/j.mam.2026.101490_bib39","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154051","article-title":"Therapeutic efficacy and safety of Yinzhihuang granules with phototherapy in neonatal pathologic jaundice: an updated systematic review and meta-analysis","volume":"100","author":"Feng","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.12968\/hmed.2022.0351","article-title":"What you need to know about gallstone disease","volume":"83","author":"Finch","year":"2022","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.mam.2026.101490_bib42","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/S0140-6736(18)30010-2","article-title":"Hepatocellular carcinoma","volume":"391","author":"Forner","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2026.101490_bib43","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1186\/s12889-024-18918-8","article-title":"Hepatitis B discrimination: global responses requiring global data","volume":"24","author":"Freeland","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.mam.2026.101490_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0070657","article-title":"An analysis of the role of the indigenous microbiota in cholesterol gallstone pathogenesis","volume":"8","author":"Fremont-Rahl","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.mam.2026.101490_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116191","article-title":"Dahuang Zhechong pill attenuates hepatic sinusoidal capillarization in liver cirrhosis and hepatocellular carcinoma rat model via the MK\/integrin signaling pathway","volume":"308","author":"Fu","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib46","doi-asserted-by":"crossref","first-page":"10632","DOI":"10.1039\/D1FO01321A","article-title":"Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota","volume":"12","author":"Fu","year":"2021","journal-title":"Food Funct."},{"key":"10.1016\/j.mam.2026.101490_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113185","article-title":"Forsythiaside A alleviated carbon tetrachloride-induced liver fibrosis by modulating gut microbiota composition to increase short-chain fatty acids and restoring bile acids metabolism disorder","volume":"151","author":"Fu","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib48","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1089\/jmf.2023.K.0273","article-title":"The potential mechanism of the anti-liver fibrotic effect of curcumin in the gut-liver axis","volume":"27","author":"Geng","year":"2024","journal-title":"J. Med. Food"},{"key":"10.1016\/j.mam.2026.101490_bib49","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0140-6736(21)01374-X","article-title":"Liver cirrhosis","volume":"398","author":"Gin\u00e8s","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.mam.2026.101490_bib50","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2021.05.022","article-title":"Burden of non-alcoholic fatty liver disease in Asia, the Middle East and North Africa: data from global burden of disease 2009-2019","volume":"75","author":"Golabi","year":"2021","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105690","article-title":"A review of pharmacological and pharmacokinetic properties of Forsythiaside A","volume":"169","author":"Gong","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mam.2026.101490_bib52","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1055\/s-0041-1732319","article-title":"Clinical application and progress of fecal microbiota transplantation in liver diseases: a review","volume":"41","author":"Gu","year":"2021","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2026.101490_bib53","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1039\/D2FO03015B","article-title":"Baicalein alleviates non-alcoholic fatty liver disease in mice by ameliorating intestinal barrier dysfunction","volume":"14","author":"Guo","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.mam.2026.101490_bib54","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1055\/s-0042-1748037","article-title":"Intestinal barrier dysfunction in fatty liver disease: roles of microbiota, mucosal immune system, and bile acids","volume":"42","author":"Gupta","year":"2022","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2026.101490_bib55","doi-asserted-by":"crossref","first-page":"23","DOI":"10.4155\/ppa-2021-0027","article-title":"Baicalein: promising therapeutic applications with special reference to published patents","volume":"11","author":"Gupta","year":"2022","journal-title":"Pharm. Pat. Anal."},{"key":"10.1016\/j.mam.2026.101490_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2020.104722","article-title":"Berberine pharmacology and the gut microbiota: a hidden therapeutic link","volume":"155","author":"Habtemariam","year":"2020","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mam.2026.101490_bib57","doi-asserted-by":"crossref","first-page":"7721","DOI":"10.1002\/jsfa.12854","article-title":"Lonicerae flos polysaccharides improve nonalcoholic fatty liver disease by activating the adenosine 5'-monophosphate-activated protein kinase pathway and reshaping gut microbiota","volume":"103","author":"Han","year":"2023","journal-title":"J. Sci. Food Agric."},{"key":"10.1016\/j.mam.2026.101490_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2022.113174","article-title":"Structural characterization and protective effect of Lonicerae flos polysaccharide on cyclophosphamide-induced immunosuppression in mice","volume":"230","author":"Han","year":"2022","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.mam.2026.101490_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153544","article-title":"Si Miao Formula attenuates non-alcoholic fatty liver disease by modulating hepatic lipid metabolism and gut microbiota","volume":"85","author":"Han","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40261-013-0136-3","article-title":"Randomized, vitamin E-controlled trial of bicyclol plus metformin in non-alcoholic fatty liver disease patients with impaired fasting glucose","volume":"34","author":"Han","year":"2014","journal-title":"Clin. Drug Invest."},{"issue":"4","key":"10.1016\/j.mam.2026.101490_bib61","first-page":"433","article-title":"Short-chain fatty acids in the gut-brain-liver axis: implications for hepatic encephalopathy","volume":"57","author":"Hasan","year":"2025","journal-title":"Acta Medica Indonesiana"},{"key":"10.1016\/j.mam.2026.101490_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117402","article-title":"Dahuang zhechong pill ameliorates hepatic fibrosis by regulating gut microbiota and metabolites","volume":"321","author":"He","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib63","article-title":"Hepatoprotective effect of curcumin against bisphenol A-induced hepatic steatosis via modulating gut microbiota dysbiosis and related gut-liver axis activation in CD-1 mice","volume":"109","author":"Hong","year":"2022","journal-title":"JNB (J. Nutr. Biochem.)"},{"key":"10.1016\/j.mam.2026.101490_bib64","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cgh.2019.07.010","article-title":"Outcomes of long-term treatment of chronic HBV infection with entecavir or other agents from a randomized trial in 24 countries","volume":"18","author":"Hou","year":"2020","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.fitote.2023.105653","article-title":"Protective effect of water extracts of Veronicastrum latifolium (Hemsl.) Yamazaki on carbon tetrachloride-induced liver fibrosis in mice and its effect on intestinal flora","volume":"170","author":"Hu","year":"2023","journal-title":"Fitoterapia"},{"key":"10.1016\/j.mam.2026.101490_bib66","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J. Gastroenterol."},{"key":"10.1016\/j.mam.2026.101490_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105444","article-title":"Baicalin and the liver-gut system: pharmacological bases explaining its therapeutic effects","volume":"165","author":"Hu","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mam.2026.101490_bib68","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1111\/imj.14709","article-title":"Non-alcoholic fatty liver disease: a review of epidemiology, risk factors, diagnosis and management","volume":"50","author":"Huang","year":"2020","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.mam.2026.101490_bib69","doi-asserted-by":"crossref","first-page":"7692","DOI":"10.1039\/D3FO01684F","article-title":"Nobiletin protects against ferroptosis to alleviate sepsis-associated acute liver injury by modulating the gut microbiota","volume":"14","author":"Huang","year":"2023","journal-title":"Food Funct."},{"key":"10.1016\/j.mam.2026.101490_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109258","article-title":"Gypenosides improve the intestinal microbiota of non-alcoholic fatty liver in mice and alleviate its progression","volume":"118","author":"Huang","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2023.175788","article-title":"Oroxin B improves metabolic-associated fatty liver disease by alleviating gut microbiota dysbiosis in a high-fat diet-induced rat model","volume":"951","author":"Huang","year":"2023","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1107071","article-title":"The spleen-strengthening and liver-draining herbal formula treatment of non-alcoholic fatty liver disease by regulation of intestinal flora in clinical trial","volume":"13","author":"Hui","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2026.101490_bib73","first-page":"8558","article-title":"Capsaicin improves glucose homeostasis by enhancing glucagon-like peptide-1 secretion through the regulation of bile acid metabolism via the remodeling of the gut microbiota in male mice","volume":"34","author":"Hui","year":"2020","journal-title":"FASEB (Fed. Am. Soc. Exp. Biol.) J."},{"key":"10.1016\/j.mam.2026.101490_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.7150\/ijbs.113217","article-title":"Procyanidin suppresses tumor growth by activating the B-Cell MAPK pathway through remodulation of the gut microbiota and metabolites in hepatocellular carcinoma","volume":"22","author":"Huo","year":"2026","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155225","article-title":"Stigmasterol: remodeling gut microbiota and suppressing tumor growth through Treg and CD8+ T cells in hepatocellular carcinoma","volume":"129","author":"Huo","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib77","first-page":"174","article-title":"The gut microbiome and ferroptosis in MAFLD","volume":"11","author":"Ji","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1038\/nrgastro.2017.119","article-title":"Bile acid-microbiota crosstalk in gastrointestinal inflammation and carcinogenesis","volume":"15","author":"Jia","year":"2018","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib78","doi-asserted-by":"crossref","first-page":"5823","DOI":"10.1002\/ptr.7240","article-title":"Gut microbiota enhances the chemosensitivity of hepatocellular carcinoma to 5-fluorouracil in vivo by increasing curcumin bioavailability","volume":"35","author":"Jin","year":"2021","journal-title":"Phytother Res."},{"key":"10.1016\/j.mam.2026.101490_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1677175","article-title":"Microbiome-mediated crosstalk between T2DM and MASLD: a translational review focused on function","volume":"16","author":"Jing","year":"2025","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2026.101490_bib79","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11418-021-01548-4","article-title":"Bie Jia Jian pill enhances the amelioration of bone mesenchymal stem cells on hepatocellular carcinoma progression","volume":"76","author":"Jingjing","year":"2022","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.mam.2026.101490_bib81","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1146\/annurev-food-041715-033159","article-title":"Bile acid modifications at the microbe-host interface: potential for nutraceutical and pharmaceutical interventions in host health","volume":"7","author":"Joyce","year":"2016","journal-title":"Annu. Rev. Food Sci. Technol."},{"key":"10.1016\/j.mam.2026.101490_bib82","article-title":"Rifaximin alleviates endotoxemia with decreased serum levels of soluble CD163 and mannose receptor and partial modification of Gut Microbiota in cirrhotic patients","volume":"9","author":"Kaji","year":"2020","journal-title":"Antibiotics (Basel)"},{"key":"10.1016\/j.mam.2026.101490_bib83","first-page":"866","article-title":"RiskRadar: development and pilot results of a technical intervention targeting combination prevention regarding HIV, viral hepatitis","volume":"21","author":"Kakalou","year":"2021","journal-title":"sexually transmitted infections and tuberculosis. BMC Infectious Diseases"},{"key":"10.1016\/j.mam.2026.101490_bib84","doi-asserted-by":"crossref","first-page":"3631","DOI":"10.1002\/cncr.29537","article-title":"Impact of long-term tenofovir disoproxil fumarate on incidence of hepatocellular carcinoma in patients with chronic hepatitis B","volume":"121","author":"Kim","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.mam.2026.101490_bib85","doi-asserted-by":"crossref","first-page":"433","DOI":"10.5483\/BMBRep.2014.47.8.153","article-title":"Stigmasterol isolated from marine microalgae Navicula incerta induces apoptosis in human hepatoma HepG2 cells","volume":"47","author":"Kim","year":"2014","journal-title":"BMB Rep."},{"key":"10.1016\/j.mam.2026.101490_bib86","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41579-020-0438-4","article-title":"Gut microbial metabolites as multi-kingdom intermediates","volume":"19","author":"Krautkramer","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib87","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1055\/a-2378-9025","article-title":"Gallstones: prevention, diagnosis, and treatment","volume":"44","author":"Lammert","year":"2024","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.mam.2026.101490_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104952","article-title":"Lactobacillus acidophilus suppresses non-alcoholic fatty liver disease-associated hepatocellular carcinoma through producing valeric acid","volume":"100","author":"Lau","year":"2024","journal-title":"EBioMedicine"},{"key":"10.1016\/j.mam.2026.101490_bib89","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2019.153135","article-title":"Amelioration of non-alcoholic steatohepatitis by Qushi Huayu decoction is associated with inhibition of the intestinal mitogen-activated protein kinase pathway","volume":"66","author":"Leng","year":"2020","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib90","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1038\/nrgastro.2016.85","article-title":"The role of the gut microbiota in NAFLD","volume":"13","author":"Leung","year":"2016","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib91","doi-asserted-by":"crossref","first-page":"350","DOI":"10.3350\/cmh.2024.0857","article-title":"Gut microbiota-mediated gut-liver axis: a breakthrough point for understanding and treating liver cancer","volume":"31","author":"Li","year":"2025","journal-title":"Clin. Mol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib92","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2021.119921","article-title":"Ferulic acid: a review of its pharmacology, pharmacokinetics and derivatives","volume":"284","author":"Li","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.mam.2026.101490_bib93","article-title":"Polysaccharide from Salviae miltiorrhizae Radix et Rhizoma Attenuates the Progress of Obesity-Induced Non-Alcoholic Fatty Liver Disease through Modulating Intestinal Microbiota-Related Gut-Liver Axis","volume":"23","author":"Li","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib94","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2020.112896","article-title":"Qiang-Gan formula extract improves non-alcoholic steatohepatitis via regulating bile acid metabolism and gut microbiota in mice","volume":"258","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib95","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.1021\/acs.jafc.2c08637","article-title":"Nobiletin ameliorates nonalcoholic fatty liver disease by regulating gut Microbiota and myristoleic acid metabolism","volume":"71","author":"Li","year":"2023","journal-title":"J. Agric. Food Chem."},{"key":"10.1016\/j.mam.2026.101490_bib96","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2024.139357","article-title":"Huaier polysaccharides inhibits hepatocellular carcinoma via gut microbiota mediated M2 macrophage polarization","volume":"293","author":"Li","year":"2025","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mam.2026.101490_bib97","article-title":"Integrated plasma metabolomics and gut microbiota analysis: the intervention effect of Jiawei Xiaoyao San on liver depression and spleen deficiency liver cancer rats","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib98","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.4254\/wjh.v14.i7.1277","article-title":"Gut microbiota contribution to hepatocellular carcinoma manifestation in non-alcoholic steatohepatitis","volume":"14","author":"Liakina","year":"2022","journal-title":"World J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib99","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.jhep.2013.05.007","article-title":"Reversal of cirrhosis: an achievable goal of hepatitis B antiviral therapy","volume":"59","author":"Liaw","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib100","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1111\/bph.12426","article-title":"GPBA: a GPCR for bile acids and an emerging therapeutic target for disorders of digestion and sensation","volume":"171","author":"Lieu","year":"2014","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib101","first-page":"330","article-title":"Colon-targeted astragalus polysaccharide nanoparticles prevent NAFLD-driven hepatocarcinogenesis via microbiota remodeling and NF-\u03baB inhibition","volume":"44","author":"Liu","year":"2025","journal-title":"Journal of Experimental & Clinical Cancer Research CR"},{"key":"10.1016\/j.mam.2026.101490_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2024.155398","article-title":"Efficacy and safety of Qushi Huayu, a traditional Chinese medicine, in patients with nonalcoholic fatty liver disease in a randomized controlled trial","volume":"130","author":"Liu","year":"2024","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib103","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/jvh.12613","article-title":"No detectable resistance to tenofovir disoproxil fumarate in HBeAg+ and HBeAg- patients with chronic hepatitis B after 8 years of treatment","volume":"24","author":"Liu","year":"2017","journal-title":"J. Viral Hepat."},{"key":"10.1016\/j.mam.2026.101490_bib104","doi-asserted-by":"crossref","DOI":"10.3390\/biom13020396","article-title":"Cellular pathogenesis of hepatic encephalopathy: an update","volume":"13","author":"Lu","year":"2023","journal-title":"Biomolecules"},{"key":"10.1016\/j.mam.2026.101490_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108753","article-title":"Ferulic acid ameliorates nonalcoholic fatty liver disease and modulates the gut microbiota composition in high-fat diet fed ApoE(-\/-) mice","volume":"113","author":"Ma","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib106","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s12072-023-10633-7","article-title":"Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update","volume":"18","author":"Mao","year":"2024","journal-title":"Hepatol. Int."},{"key":"10.1016\/j.mam.2026.101490_bib108","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1139\/y98-049","article-title":"The gut as a potential trigger of exercise-induced inflammatory responses","volume":"76","author":"Marshall","year":"1998","journal-title":"Can. J. Physiol. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib109","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/j.cgh.2021.07.036","article-title":"Treatment algorithm for managing chronic hepatitis B virus infection in the United States: 2021 update","volume":"20","author":"Martin","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib107","doi-asserted-by":"crossref","first-page":"6377","DOI":"10.3390\/cimb46070381","article-title":"The role of microbiota-related Co-Metabolites in MASLD progression: a narrative review","volume":"46","author":"Martin-Grau","year":"2024","journal-title":"Curr. Issues Mol. Biol."},{"key":"10.1016\/j.mam.2026.101490_bib110","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1001\/jama.2020.20317","article-title":"Acute pancreatitis: a review","volume":"325","author":"Mederos","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.mam.2026.101490_bib111","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s11655-025-4127-z","article-title":"Sini powder alleviates stress response and suppresses hepatocellular carcinoma development by restoring gut microbiota","volume":"31","author":"Mei","year":"2025","journal-title":"Chin. J. Integr. Med."},{"key":"10.1016\/j.mam.2026.101490_bib112","doi-asserted-by":"crossref","first-page":"4568","DOI":"10.3390\/ijms20184568","article-title":"Alcohol or gut microbiota: who is the guilty?","volume":"20","author":"Meroni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20020395","article-title":"Gut-liver axis, gut microbiota, and its modulation in the management of liver diseases: a review of the literature","volume":"20","author":"Milosevic","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib114","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1272214","article-title":"Qushi Huayu decoction ameliorates non-alcoholic fatty liver disease in rats by modulating gut microbiota and serum lipids","volume":"14","author":"Ni","year":"2023","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2026.101490_bib115","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2021.1972746","article-title":"Ursolic acid reverses liver fibrosis by inhibiting NOX4\/NLRP3 inflammasome pathways and bacterial dysbiosis","volume":"13","author":"Nie","year":"2021","journal-title":"Gut Microbes"},{"key":"10.1016\/j.mam.2026.101490_bib116","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s42000-022-00391-w","article-title":"Detangling the interrelations between MAFLD, insulin resistance, and key hormones","volume":"21","author":"Pal","year":"2022","journal-title":"Hormones (Basel)"},{"key":"10.1016\/j.mam.2026.101490_bib117","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.mam.2018.09.002","article-title":"Liver fibrosis: pathophysiology, pathogenetic targets and clinical issues","volume":"65","author":"Parola","year":"2019","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.mam.2026.101490_bib118","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/joim.13531","article-title":"Current treatment of non-alcoholic fatty liver disease","volume":"292","author":"Paternostro","year":"2022","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.mam.2026.101490_bib119","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.jhep.2012.02.033","article-title":"Hepatitis B virus-related decompensated liver cirrhosis: benefits of antiviral therapy","volume":"57","author":"Peng","year":"2012","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib120","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin","year":"2018","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib121","doi-asserted-by":"crossref","first-page":"996","DOI":"10.15252\/msb.20178155","article-title":"Methods to drive systems biology forward","volume":"13","author":"Polychronidou","year":"2017","journal-title":"Mol. Syst. Biol."},{"key":"10.1016\/j.mam.2026.101490_bib122","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12902-022-00980-1","article-title":"Non-alcoholic fatty liver disease (NAFLD): a review of pathophysiology, clinical management and effects of weight loss","volume":"22","author":"Pouwels","year":"2022","journal-title":"BMC Endocr. Disord."},{"key":"10.1016\/j.mam.2026.101490_bib123","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1080\/08830185.2026.2614779","article-title":"Comprehensive review on immunotherapy for hepatocellular carcinoma: current status and future perspectives","volume":"45","author":"Pulakuntla","year":"2026","journal-title":"Int. Rev. Immunol."},{"key":"10.1016\/j.mam.2026.101490_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116666","article-title":"Integrating metabonomics and metagenomics sequencing to study the anti-liver fibrosis effects of palmatine in Corydalis saxicola bunting","volume":"315","author":"Qin","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib125","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature13568","article-title":"Alterations of the human gut microbiome in liver cirrhosis","volume":"513","author":"Qin","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101490_bib126","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cbdd.14241","article-title":"Glaucocalyxin A attenuates carbon tetrachloride-induced liver fibrosis and improves the associated gut microbiota imbalance","volume":"102","author":"Qu","year":"2023","journal-title":"Chem. Biol. Drug Des."},{"key":"10.1016\/j.mam.2026.101490_bib127","doi-asserted-by":"crossref","DOI":"10.1080\/19490976.2023.2240031","article-title":"Unveiling the complex relationship between gut microbiota and liver cancer: opportunities for novel therapeutic interventions","volume":"15","author":"Rajapakse","year":"2023","journal-title":"Gut Microbes"},{"key":"10.1016\/j.mam.2026.101490_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2021.153647","article-title":"Honokiol: a review of its pharmacological potential and therapeutic insights","volume":"90","author":"Rauf","year":"2021","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib129","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrgastro.2013.121","article-title":"Gut microbiota: Obesity-induced microbial metabolite promotes HCC","volume":"10","author":"Ray","year":"2013","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib130","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"The Lancet. Gastroenterology & Hepatology"},{"key":"10.1016\/j.mam.2026.101490_bib131","doi-asserted-by":"crossref","DOI":"10.3390\/cells10123406","article-title":"Maresin-1 prevents liver fibrosis by targeting Nrf2 and NF-\u03baB, reducing oxidative stress and inflammation","volume":"10","author":"Rodr\u00edguez","year":"2021","journal-title":"Cells"},{"key":"10.1016\/j.mam.2026.101490_bib132","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/1747493018778713","article-title":"Multisociety consensus quality improvement revised consensus statement for endovascular therapy of acute ischemic stroke","volume":"13","author":"Sacks","year":"2018","journal-title":"Int. J. Stroke"},{"key":"10.1016\/j.mam.2026.101490_bib133","first-page":"1503","article-title":"Financial burden and social implications of chronic liver disease in a patient population group in Pakistan","volume":"40","author":"Salim","year":"2024","journal-title":"Pakistan J. Med. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib134","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/s41575-021-00438-0","article-title":"Advances in immunotherapy for hepatocellular carcinoma","volume":"18","author":"Sangro","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib135","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/s41586-020-2971-8","article-title":"The gut microbiota is associated with immune cell dynamics in humans","volume":"588","author":"Schluter","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.mam.2026.101490_bib136","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.mam.2026.101490_bib137","doi-asserted-by":"crossref","first-page":"3964","DOI":"10.1038\/s41467-022-31312-5","article-title":"Imbalanced gut microbiota fuels hepatocellular carcinoma development by shaping the hepatic inflammatory microenvironment","volume":"13","author":"Schneider","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.mam.2026.101490_bib138","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jhep.2019.08.016","article-title":"Gut microbiome in HCC - Mechanisms, diagnosis and therapy","volume":"72","author":"Schwabe","year":"2020","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib139","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1080\/17474124.2021.1949289","article-title":"Chronic liver disease and oxidative stress - a narrative review","volume":"15","author":"Seen","year":"2021","journal-title":"Expert Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib140","doi-asserted-by":"crossref","DOI":"10.1126\/science.abc4552","article-title":"The microbiome and human cancer","volume":"371","author":"Sepich-Poore","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.mam.2026.101490_bib141","doi-asserted-by":"crossref","DOI":"10.1016\/j.foodres.2023.113161","article-title":"Potentialities of Ganoderma lucidum extracts as functional ingredients in food formulation","volume":"172","author":"Sharif Swallah","year":"2023","journal-title":"Food Res. Int."},{"key":"10.1016\/j.mam.2026.101490_bib142","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.154842","article-title":"Berberine activates PPAR\u03b4 and promotes gut microbiota-derived butyric acid to suppress hepatocellular carcinoma","volume":"115","author":"Shou","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib143","first-page":"12","article-title":"Cancer statistics, 2024","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mam.2026.101490_bib144","doi-asserted-by":"crossref","first-page":"5897","DOI":"10.3748\/wjg.v25.i39.5897","article-title":"Gut-liver axis signaling in portal hypertension","volume":"25","author":"Simbrunner","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mam.2026.101490_bib145","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.bbalip.2016.10.006","article-title":"Lipopolysaccharide biogenesis and transport at the outer membrane of Gram-negative bacteria","volume":"1862","author":"Sperandeo","year":"2017","journal-title":"Biochim. Biophys. Acta, Mol. Cell Biol. Lipids"},{"key":"10.1016\/j.mam.2026.101490_bib146","first-page":"209","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.mam.2026.101490_bib147","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s40200-025-01606-8","article-title":"A scientometric analysis and visualization of research on fatty liver diseases in Iran from 2003 to 2023","volume":"24","author":"Taheri","year":"2025","journal-title":"J. Diabetes Metab. Disord."},{"key":"10.1016\/j.mam.2026.101490_bib148","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv. Immunol."},{"key":"10.1016\/j.mam.2026.101490_bib149","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116418","article-title":"Integrated serum pharmacochemistry, 16S rRNA sequencing and metabolomics to reveal the material basis and mechanism of Yinzhihuang granule against non-alcoholic fatty liver disease","volume":"310","author":"Tan","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib150","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.jphs.2020.04.007","article-title":"Administration of a mixture of triterpenoids from yeyachun and phenolic acids from danshen ameliorates carbon tetrachloride-induced liver fibrosis in mice by the regulation of intestinal flora","volume":"143","author":"Tan","year":"2020","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2022.154208","article-title":"The improvement of nonalcoholic steatohepatitis by Poria cocos polysaccharides associated with gut microbiota and NF-\u03baB\/CCL3\/CCR1 axis","volume":"103","author":"Tan","year":"2022","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib152","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab."},{"key":"10.1016\/j.mam.2026.101490_bib153","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMra1713263","article-title":"Hepatocellular carcinoma","volume":"380","author":"Villanueva","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mam.2026.101490_bib154","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/hep.27210","article-title":"Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the American association for the study of liver diseases and the european association for the study of the liver","volume":"60","author":"Vilstrup","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2026.101490_bib155","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1016\/j.cgh.2017.04.016","article-title":"A randomized trial of silymarin for the treatment of nonalcoholic steatohepatitis","volume":"15","author":"Wah Kheong","year":"2017","journal-title":"Clin. Gastroenterol. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib156","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.cmet.2016.05.005","article-title":"Intestinal crosstalk between bile acids and microbiota and its impact on host metabolism","volume":"24","author":"Wahlstr\u00f6m","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.mam.2026.101490_bib157","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3389\/fphar.2019.01321","article-title":"Ursolic acid improves intestinal damage and bacterial dysbiosis in liver fibrosis mice","volume":"10","author":"Wan","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib158","article-title":"Long-term trends of liver cancer incidence and mortality in China 1990-2017: a joinpoint and age-period-cohort analysis","volume":"16","author":"Wang","year":"2019","journal-title":"Int. J. Environ. Res. Publ. Health"},{"key":"10.1016\/j.mam.2026.101490_bib159","doi-asserted-by":"crossref","first-page":"496","DOI":"10.14218\/JCTH.2021.00425","article-title":"Tumor-associated exosomes are involved in hepatocellular carcinoma tumorigenesis, diagnosis, and treatment","volume":"10","author":"Wang","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib160","doi-asserted-by":"crossref","DOI":"10.1016\/j.biocel.2025.106873","article-title":"Bielong Ruangan decoction inhibits tumor growth and improves immune response in a hepatocellular carcinoma mouse model through gut microbiota","volume":"190","author":"Wang","year":"2026","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"10.1016\/j.mam.2026.101490_bib161","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.03242-22","article-title":"Transcriptome and gut microbiota profiling analysis of ANIT-induced cholestasis and the effects of da-huang-xiao-shi decoction intervention","volume":"10","author":"Wang","year":"2022","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.mam.2026.101490_bib162","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4093\/dmj.2019.0042","article-title":"Combination of probiotics and Salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice","volume":"44","author":"Wang","year":"2020","journal-title":"Diabetes & Metabolism Journal"},{"key":"10.1016\/j.mam.2026.101490_bib163","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s13668-024-00564-6","article-title":"The role of short-chain fatty acids in myocardial ischemia-reperfusion injury","volume":"13","author":"Wang","year":"2024","journal-title":"Current Nutrition Reports"},{"key":"10.1016\/j.mam.2026.101490_bib164","doi-asserted-by":"crossref","first-page":"8589","DOI":"10.1038\/s41598-022-11041-x","article-title":"Influence of Pholiota adiposa on gut microbiota and promote tumor cell apoptosis properties in H22 tumor-bearing mice","volume":"12","author":"Wang","year":"2022","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101490_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/antiox11112234","article-title":"Comprehensive effect of carbon tetrachloride and reversal of gandankang formula in mice liver: involved in oxidative stress, excessive inflammation, and intestinal microflora","volume":"11","author":"Wei","year":"2022","journal-title":"Antioxidants"},{"key":"10.1016\/j.mam.2026.101490_bib166","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2023.114527","article-title":"Acute liver injury induced by carbon tetrachloride reversal by Gandankang aqueous extracts through nuclear factor erythroid 2-related factor 2 signaling pathway","volume":"251","author":"Wei","year":"2023","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"10.1016\/j.mam.2026.101490_bib167","first-page":"559","article-title":"Effects of Zhenggan Huayu decoction combined with entecavir on gut microbiota in patients with chronic hepatitis B fibrosis","volume":"43","author":"Wenlin","year":"2023","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.mam.2026.101490_bib168","first-page":"437","article-title":"Cirrhosis","volume":"106","author":"Wilson","year":"2022","journal-title":"Med. Clin."},{"key":"10.1016\/j.mam.2026.101490_bib169","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1016\/j.jhep.2013.04.013","article-title":"Community-based lifestyle modification programme for non-alcoholic fatty liver disease: a randomized controlled trial","volume":"59","author":"Wong","year":"2013","journal-title":"J. Hepatol."},{"key":"10.1016\/j.mam.2026.101490_bib170","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1111\/apt.14397","article-title":"Review article: the gut microbiome as a therapeutic target in the pathogenesis and treatment of chronic liver disease","volume":"47","author":"Woodhouse","year":"2018","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.mam.2026.101490_bib171","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117228","article-title":"Molecular mechanism and therapeutic strategy of bile acids in Alzheimer's disease from the emerging perspective of the microbiota-gut-brain axis","volume":"178","author":"Wu","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib172","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2019.104454","article-title":"Zn(II)-curcumin solid dispersion impairs hepatocellular carcinoma growth and enhances chemotherapy by modulating gut microbiota-mediated zinc homeostasis","volume":"150","author":"Wu","year":"2019","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.mam.2026.101490_bib173","doi-asserted-by":"crossref","first-page":"327","DOI":"10.31083\/j.fbl2812327","article-title":"Quercetin\/Anti-PD-1 antibody combination therapy regulates the Gut microbiota, impacts macrophage immunity and reshapes the hepatocellular carcinoma tumor microenvironment","volume":"28","author":"Wu","year":"2023","journal-title":"Frontiers in Bioscience (Landmark edition)"},{"key":"10.1016\/j.mam.2026.101490_bib174","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1186\/1471-2164-14-669","article-title":"Gut microbiota dysbiosis and bacterial community assembly associated with cholesterol gallstones in large-scale study","volume":"14","author":"Wu","year":"2013","journal-title":"BMC Genom."},{"key":"10.1016\/j.mam.2026.101490_bib175","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1097\/CM9.0000000000002108","article-title":"Cancer statistics in China and United States, 2022: profiles, trends, and determinants","volume":"135","author":"Xia","year":"2022","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.mam.2026.101490_bib176","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.117273","article-title":"A novel intervention of molecular hydrogen on the unbalance of the gut microbiome in opioid addiction: experimental and human studies","volume":"178","author":"Xie","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib177","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/jam.15307","article-title":"Effects of ganfule capsule on microbial and metabolic profiles in anti-hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J. Appl. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib178","article-title":"Involvement of bile acid metabolism and gut microbiota in the amelioration of experimental metabolism-associated fatty liver disease by nobiletin","volume":"29","author":"Xu","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.mam.2026.101490_bib179","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2024.118147","article-title":"Paeonol attenuates nonalcoholic steatohepatitis by regulating intestinal flora and AhR\/NLRP3\/Caspase-1 metabolic pathway","volume":"329","author":"Yan","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib180","article-title":"Chinese herbal decoction, yi-qi-jian-pi formula exerts anti-hepatic fibrosis effects in mouse models of CCl(4)-induced liver fibrosis","volume":"10","author":"Yang","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.mam.2026.101490_bib181","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2023.1147067","article-title":"Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice","volume":"14","author":"Yao","year":"2023","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib182","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115457","article-title":"Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis","volume":"296","author":"Ye","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib183","first-page":"988","article-title":"Effectiveness of Jiedu granule on gut microbiota in patients with advanced hepatocellular carcinoma: a randomized controlled trial","volume":"42","author":"Yifu","year":"2022","journal-title":"J. Tradit. Chin. Med."},{"key":"10.1016\/j.mam.2026.101490_bib184","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s12275-024-00137-w","article-title":"Structural insights into the lipopolysaccharide transport (Lpt) system as a novel antibiotic target","volume":"62","author":"Yoon","year":"2024","journal-title":"J. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib185","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1002\/hep.23845","article-title":"Endotoxin accumulation prevents carcinogen-induced apoptosis and promotes liver tumorigenesis in rodents","volume":"52","author":"Yu","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.mam.2026.101490_bib186","doi-asserted-by":"crossref","DOI":"10.1002\/mco2.70121","article-title":"The malignant transformation of viral hepatitis to hepatocellular carcinoma: mechanisms and interventions","volume":"6","author":"Yuan","year":"2025","journal-title":"MedComm"},{"key":"10.1016\/j.mam.2026.101490_bib187","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.885039","article-title":"Gynostemma pentaphyllum polysaccharides ameliorate non-alcoholic steatohepatitis in mice associated with gut microbiota and the TLR2\/NLRP3 pathway","volume":"13","author":"Yue","year":"2022","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.mam.2026.101490_bib188","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1038\/s43018-023-00618-8","article-title":"Performance and effectiveness of hepatocellular carcinoma screening in individuals with HBsAg seropositivity in China: a multicenter prospective study","volume":"4","author":"Zeng","year":"2023","journal-title":"Nat. Cancer"},{"key":"10.1016\/j.mam.2026.101490_bib189","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000543834","article-title":"Xiayuxue decoction plays an antidevelopment role in hepatocellular carcinoma through intestinal-hepatic axis","volume":"106","author":"Zeng","year":"2025","journal-title":"Digestion"},{"key":"10.1016\/j.mam.2026.101490_bib190","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s10787-024-01447-6","article-title":"Curcumol: a review of its pharmacology, pharmacokinetics, drug delivery systems, structure-activity relationships, and potential applications","volume":"32","author":"Zhai","year":"2024","journal-title":"Inflammopharmacology"},{"key":"10.1016\/j.mam.2026.101490_bib191","doi-asserted-by":"crossref","first-page":"15203","DOI":"10.1038\/s41598-023-42358-w","article-title":"Honokiol affects the composition of gut microbiota and the metabolism of lipid and bile acid in methionine-choline deficiency diet-induced NASH mice","volume":"13","author":"Zhai","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mam.2026.101490_bib192","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J. Cancer Res. Clin. Oncol."},{"key":"10.1016\/j.mam.2026.101490_bib193","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1080\/13880209.2020.1855212","article-title":"Hepatoprotective effect of Xiayuxue decoction ethyl acetate fraction against carbon tetrachloride-induced liver fibrosis in mice via inducing apoptosis and suppressing activation of hepatic stellate cells","volume":"58","author":"Zhang","year":"2020","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.mam.2026.101490_bib194","article-title":"Exploring the multicomponent synergy mechanism of Yinzhihuang Granule in inhibiting inflammation-cancer transformation of hepar based on integrated bioinformatics and network pharmacology","volume":"2022","author":"Zhang","year":"2022","journal-title":"BioMed Res. Int."},{"key":"10.1016\/j.mam.2026.101490_bib195","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117656","article-title":"Ganoderma lucidum ethanol extracts ameliorate hepatic fibrosis and promote the communication between metabolites and gut microbiota g_Ruminococcus through the NF-\u03baB and TGF-\u03b21\/Smads pathways","volume":"322","author":"Zhang","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib196","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.116811","article-title":"Erchen decoction alleviates obesity-related hepatic steatosis via modulating gut microbiota-drived butyric acid contents and promoting fatty acid \u03b2-oxidation","volume":"317","author":"Zhang","year":"2023","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib197","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijbiomac.2021.12.036","article-title":"MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila","volume":"196","author":"Zhang","year":"2022","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.mam.2026.101490_bib198","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2025.121028","article-title":"Dual targeting by Artemisia rupestris L. disrupting TLR4\/NF-\u03baB signaling and macrophage driven immune evasion in hepatocellular carcinoma","volume":"358","author":"Zhang","year":"2026","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib199","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1136\/gutjnl-2019-319664","article-title":"Dietary cholesterol drives fatty liver-associated liver cancer by modulating gut microbiota and metabolites","volume":"70","author":"Zhang","year":"2021","journal-title":"Gut"},{"key":"10.1016\/j.mam.2026.101490_bib200","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/jcmm.16209","article-title":"Hepatic stellate cells specific liposomes with the Toll-like receptor 4 shRNA attenuates liver fibrosis","volume":"25","author":"Zhang","year":"2021","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.mam.2026.101490_bib201","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s12964-025-02625-x","article-title":"Targeting gut-liver-kidney axis: microbiota-derived metabolites and therapeutic implications","volume":"24","author":"Zhang","year":"2026","journal-title":"Cell Commun. Signal. : CCS"},{"key":"10.1016\/j.mam.2026.101490_bib202","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib203","doi-asserted-by":"crossref","DOI":"10.1016\/j.phymed.2023.155068","article-title":"Microbial modifications with Lycium barbarum L. oligosaccharides decrease hepatic fibrosis and mitochondrial abnormalities in mice","volume":"120","author":"Zhang","year":"2023","journal-title":"Phytomedicine"},{"key":"10.1016\/j.mam.2026.101490_bib204","doi-asserted-by":"crossref","DOI":"10.1002\/cbdv.202100520","article-title":"Traditional Chinese medicine ganshuang granules attenuate CCl(4) -Induced hepatic fibrosis by modulating Gut Microbiota","volume":"18","author":"Zhao","year":"2021","journal-title":"Chem. Biodivers."},{"key":"10.1016\/j.mam.2026.101490_bib205","article-title":"Deciphering the underlying mechanisms of formula le-cao-shi against liver injuries by integrating network pharmacology, metabonomics, and experimental validation","volume":"13","author":"Zhao","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib206","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.112692","article-title":"The underlying mechanisms of anti-hepatitis B effects of formula le-cao-shi and its single herbs by network pharmacology and gut microbiota analysis","volume":"148","author":"Zhao","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib207","doi-asserted-by":"crossref","first-page":"9423","DOI":"10.7314\/APJCP.2014.15.21.9423","article-title":"Influence of Chongcao Yigan Capsule on function of intestinal flora and chemoprevention for patients with chronic hepatitis B-induced liver fibrosis","volume":"15","author":"Zhao","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.mam.2026.101490_bib208","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jphs.2022.10.001","article-title":"Aronia melanocarpa polysaccharide ameliorates liver fibrosis through TGF-\u03b21-mediated the activation of PI3K\/AKT pathway and modulating gut microbiota","volume":"150","author":"Zhao","year":"2022","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.mam.2026.101490_bib209","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2023.117383","article-title":"Bile acids metabolism involved in the beneficial effects of Danggui Shaoyao San via gut microbiota in the treatment of CCl(4) induced hepatic fibrosis","volume":"319","author":"Zhao","year":"2024","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib210","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1142\/S0192415X25500168","article-title":"Chinese medicine for the treatment of liver cirrhosis: the mechanism of cellular autophagy","volume":"53","author":"Zheng","year":"2025","journal-title":"Am. J. Chin. Med."},{"key":"10.1016\/j.mam.2026.101490_bib211","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.113204","article-title":"Gut microbiota combined with metabolomics reveal the mechanism of curcumol on liver fibrosis in mice","volume":"152","author":"Zheng","year":"2022","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.mam.2026.101490_bib212","first-page":"1","article-title":"Sodium butyrate reduces high-fat diet-induced non-alcoholic steatohepatitis through upregulation of hepatic GLP-1R expression","volume":"50","author":"Zhou","year":"2018","journal-title":"Experimental & molecular medicine"},{"key":"10.1016\/j.mam.2026.101490_bib213","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.15225","article-title":"Gypenosides ameliorate high-fat diet-induced nonalcoholic fatty liver disease in mice by regulating lipid metabolism","volume":"11","author":"Zhou","year":"2023","journal-title":"PeerJ"},{"key":"10.1016\/j.mam.2026.101490_bib214","doi-asserted-by":"crossref","first-page":"7312","DOI":"10.3748\/wjg.v20.i23.7312","article-title":"Pathogenesis of liver cirrhosis","volume":"20","author":"Zhou","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mam.2026.101490_bib215","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.bbadis.2017.11.009","article-title":"Serine prevented high-fat diet-induced oxidative stress by activating AMPK and epigenetically modulating the expression of glutathione synthesis-related genes. Biochimica et Biophysica Acta","volume":"1864","author":"Zhou","year":"2018","journal-title":"Molecular Basis of Disease"},{"key":"10.1016\/j.mam.2026.101490_bib216","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13045-020-01028-4","article-title":"Hepatic NOD2 promotes hepatocarcinogenesis via a RIP2-mediated proinflammatory response and a novel nuclear autophagy-mediated DNA damage mechanism","volume":"14","author":"Zhou","year":"2021","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.mam.2026.101490_bib217","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.hbpd.2022.09.004","article-title":"Impact of cirrhosis-related complications on posttransplant survival in patients with acute-on-chronic liver failure","volume":"22","author":"Zhu","year":"2023","journal-title":"Hepatobiliary Pancreat. Dis. Int."},{"key":"10.1016\/j.mam.2026.101490_bib218","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.3748\/wjg.v25.i24.3056","article-title":"Freeze-dried si-ni-san powder can ameliorate high fat diet-induced non-alcoholic fatty liver disease","volume":"25","author":"Zhu","year":"2019","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mam.2026.101490_bib219","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2023.1066053","article-title":"Lingguizhugan decoction improves non-alcoholic steatohepatitis partially by modulating gut microbiota and correlated metabolites","volume":"13","author":"Zhu","year":"2023","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.mam.2026.101490_bib220","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2025.114091","article-title":"THSWD upregulates the LTF\/AMPK\/mTOR\/Becn1 axis and promotes lysosomal autophagy in hepatocellular carcinoma cells by regulating gut flora and metabolic reprogramming","volume":"148","author":"Zhu","year":"2025","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.mam.2026.101490_bib221","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2022.114002","article-title":"Zuogui-Jiangtang-Qinggan-Fang alleviates high-fat diet-induced type 2 diabetes mellitus with non-alcoholic fatty liver disease by modulating gut microbiome-metabolites-short chain fatty acid composition","volume":"157","author":"Zou","year":"2023","journal-title":"Biomed. Pharmacother."}],"container-title":["Molecular Aspects of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000464?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0098299726000464?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T03:24:08Z","timestamp":1785900248000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0098299726000464"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":221,"alternative-id":["S0098299726000464"],"URL":"https:\/\/doi.org\/10.1016\/j.mam.2026.101490","relation":{},"ISSN":["0098-2997"],"issn-type":[{"value":"0098-2997","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gut microbiota dysbiosis in chronic liver disease: Mechanisms driving hepatocellular carcinoma progression and therapeutic implications of Chinese medicine","name":"articletitle","label":"Article Title"},{"value":"Molecular Aspects of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mam.2026.101490","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"101490"}}